1. Home
  2. ANIX vs OESX Comparison

ANIX vs OESX Comparison

Compare ANIX & OESX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.74

Market Cap

114.0M

Sector

Health Care

ML Signal

HOLD

OESX

Orion Energy Systems Inc.

HOLD

Current Price

$28.40

Market Cap

103.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIX
OESX
Founded
1982
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Products
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
114.0M
103.4M
IPO Year
2013
2007

Fundamental Metrics

Financial Performance
Metric
ANIX
OESX
Price
$2.74
$28.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$8.67
$17.50
AVG Volume (30 Days)
365.4K
98.0K
Earning Date
05-27-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
12.82
N/A
EPS
N/A
0.47
Revenue
$210,000.00
$86,306,000.00
Revenue This Year
N/A
$7.94
Revenue Next Year
N/A
$13.89
P/E Ratio
N/A
$61.79
Revenue Growth
N/A
8.26
52 Week Low
$2.32
$7.88
52 Week High
$5.46
$31.00

Technical Indicators

Market Signals
Indicator
ANIX
OESX
Relative Strength Index (RSI) N/A 63.59
Support Level N/A $8.98
Resistance Level N/A $31.00
Average True Range (ATR) 0.00 2.31
MACD 0.00 -0.17
Stochastic Oscillator 0.00 76.11

Price Performance

Historical Comparison
ANIX
OESX

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

About OESX Orion Energy Systems Inc.

Orion Energy Systems Inc provide light emitting diode (LED) lighting systems, wireless Internet of Things (IoT) enabled control solutions, commercial and industrial electric vehicle charging infrastructure solutions and lighting and electrical maintenance services. It help its customers achieve their sustainability, energy savings and carbon footprint reduction goals through technology and exceptional service. It sell its products and services into many vertical markets within the broader commercial and industrial market segment. Primary verticals include box retail, manufacturing, warehousing/logistics, federal and municipal government, healthcare and schools. It has three segments Lighting, Maintenance, and EV segment. It generates majority of revenue from Lighting segment.

Share on Social Networks: